We are live on ! Find out more
FBT icon

First Trust NYSE Arca Biotechnology Index Fund
FBT

251 hedge funds and large institutions have $536M invested in First Trust NYSE Arca Biotechnology Index Fund in 2024 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 58 increasing their positions, 88 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 24

3% more funds holding

Funds holding: 243 → 251 (+8)

1.14% more ownership

Funds ownership: 47.55% → 48.69% (+1.1%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less capital invested

Capital invested by funds: $559M → $536M (-$23.6M)

34% less repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 88

Holders
251
Holders Change
+8
Holders Change %
+3.29%
% of All Funds
3.63%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
34
Increased
58
Reduced
88
Closed
24
Calls
$2.94M
Puts
–
Net Calls
+$2.94M
Net Calls Change
+$634K

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$6.1M
2
CAG
Csenge Advisory Group
Florida
+$4.01M
3
EAM
Empirical Asset Management
Massachusetts
+$3.38M
4
NA
Navellier & Associates
Nevada
+$3.2M
5
NW
NewEdge Wealth
Pennsylvania
+$3.1M

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$8.61M
2
LPL Financial
LPL Financial
California
-$7.7M
3
Morgan Stanley
Morgan Stanley
New York
-$7.49M
4
UBS Group
UBS Group
Switzerland
-$4.84M
5
RJA
Raymond James & Associates
Florida
-$4.66M
Name Holding Trade Value Shares
Change 		Change in
Stake
FAM
151
Family Asset Management
South Carolina
$250K – – –
FAIM
152
Financial Advocates Investment Management
Washington
$245K -$203K -1,355 -46%
CPIA
153
Cornell Pochily Investment Advisors
New York
$244K -$9.9K -66 -4%
SFP
154
Shepherd Financial Partners
Massachusetts
$241K – – –
CAL
155
Capital Analysts LLC
Pennsylvania
$240K – – –
WIP
156
WealthCare Investment Partners
Rhode Island
$238K -$44K -293 -16%
HF
157
HRT Financial
New York
$238K +$232K +1,548 New
WWM
158
Western Wealth Management
Colorado
$235K +$2.55K +17 +1%
NPFS
159
Novak & Powell Financial Services
Florida
$233K – – –
GRP
160
Global Retirement Partners
California
$228K +$3.3K +22 +2%
BlackRock
161
BlackRock
New York
$228K +$199K +1,327 +879%
Bank of Montreal
162
Bank of Montreal
Ontario, Canada
$222K -$249K -1,657 -54%
RWS
163
Resolute Wealth Strategies
Mississippi
$219K -$21K -140 -9%
TA
164
TFG Advisers
Michigan
$216K -$110K -733 -34%
JCM
165
Jacobi Capital Management
Pennsylvania
$216K -$7.8K -52 -4%
PA
166
PFG Advisors
Arizona
$208K +$203K +1,351 New
HAG
167
HF Advisory Group
Maryland
$205K +$200K +1,333 New
CA
168
Clearstead Advisors
Ohio
$182K – – –
TCM
169
TD Capital Management
Tennessee
$176K +$10.4K +69 +6%
IAIM
170
International Assets Investment Management
Florida
$166K +$162K +1,079 New
Fidelity Investments
171
Fidelity Investments
Massachusetts
$158K +$5.7K +38 +4%
BC
172
Barrett & Company
Rhode Island
$148K – – –
RFG
173
REAP Financial Group
Texas
$148K -$66.3K -442 -32%
HGERS
174
Householder Group Estate & Retirement Specialist
Arizona
$144K +$600 +4 +0.4%
PNC Financial Services Group
175
PNC Financial Services Group
Pennsylvania
$131K – – –
5 6
7
8 9

FBT Hedge Fund Activity: Q2 2024 in Review

251 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q2 2024, worth a combined $536M — down 4.2% from $559M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new FBT positions and 24 closed out — a net gain of 10 holders — while 58 added to existing stakes and 88 trimmed.

The largest buyer was Jane Street, adding an estimated $6.1M. The largest seller was Wells Fargo, cutting an estimated $8.61M.

  • 251 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q2 2024, up from 243 in Q1 2024.
  • Funds reported $536M of First Trust NYSE Arca Biotechnology Index Fund stock for Q2 2024, down 4.2% quarter-over-quarter.
  • 34 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q2 2024 and 24 closed out, a net change of +10 holders.
  • The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q2 2024 was Jane Street, an estimated $6.1M added.
  • The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q2 2024 was Wells Fargo, an estimated $8.61M sold.

Based on aggregated 13F filings for Q2 2024.